| Items | Drug Registration information |
|---|---|
| ID | 1588 |
| No | 1588 |
| Brand Name | ALICAPASE |
| Ingredients | CAPIVASERTIB 20 MG |
| Dosage Form | TABLET |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 64'S |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | FOR THE TREATMENT OF ADULT PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER WITH ONE OR MORE PIK3CA/AKT1/PTEN-ALTERATIONS |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | WHITE TABLETS |
| Note | |
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 07 L 1133/24 |
| FDD Registration Date | 12/07/2024 |
| Expiry Date | 11/07/2027 |